Biogen Investigacion FI (BIOINVS:SM)
was acquired by POP:SM
Biogen Investigacion FI an open-end fund incorporated in Spain. The Fund's objective is capital appreciation. The Fund invests in international equity securities that are engaged in the health and biotechnology sector, mainly in the OECD markets. Additionally, The Fund invests in derivative instruments.